Comparative Effectiveness Research Group Takes On Hep C Rx Sovaldi

By John Wilkerson / June 26, 2014 at 5:29 PM
The comparative effectiveness research group Center for Medical Technology Policy is jumping into the fray on the price of Sovaldi by holding a web conference July 7 on the evidence needed to assess the value of the Hepatitis C drug. Some believe Sovaldi is a prime candidate for comparative effectiveness research, but the drug industry typically opposes comparing the value of drugs and was instrumental in preventing government-funded research from considering the cost of treatments. The web conference will include...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.